Unknown

Dataset Information

0

Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study.


ABSTRACT:

Background

Hodgkin's lymphoma (HL) constitutes 10%-20% of all malignant lymphomas and has a high cure rate (5-year survival, around 90%). Recently, interest has increased concerning preventing secondary complications (secondary cancer, endocrine disorders) in long-term survivors. We aimed to study the epidemiologic features and therapeutic outcomes of HL in children, adolescents, and young adults in Korea.

Methods

We performed a multicenter, retrospective study of 224 patients aged < 25 years diagnosed with HL at 22 participating institutes in Korea from January 2007 to August 2016.

Results

A higher percentage of males was diagnosed at a younger age. Nodular sclerosis histopathological HL subtype was most common, followed by mixed cellularity subtype. Eighty-one (36.2%), 101 (45.1%), and 42 (18.8%) patients were classified into low, intermediate, and high-risk groups, respectively. Doxorubicin, bleomycin, vinblastine, dacarbazine was the most common protocol (n = 102, 45.5%). Event-free survival rate was 86.0% ± 2.4%, while five-year overall survival (OS) rate was 96.1% ± 1.4%: 98.7% ± 1.3%, 97.7% ± 1.6%, and 86.5% ± 5.6% in the low, intermediate, and high-risk groups, respectively (P = 0.021). Five-year OS was worse in patients with B-symptoms, stage IV disease, high-risk, splenic involvement, extra-nodal lymphoma, and elevated lactate dehydrogenase level. In multivariate analysis, B-symptoms and extra-nodal involvement were prognostic factors for poor OS. Late complications of endocrine disorders and secondary malignancy were observed in 17 and 6 patients, respectively.

Conclusion

This is the first study on the epidemiology and treatment outcomes of HL in children, adolescents, and young adults in Korea. Future prospective studies are indicated to develop therapies that minimize treatment toxicity while maximizing cure rates in children, adolescents, and young adults with HL.

SUBMITTER: Lee JM 

PROVIDER: S-EPMC7707923 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study.

Lee Jae Min JM   Choi Jung Yoon JY   Hong Kyung Taek KT   Kang Hyoung Jin HJ   Shin Hee Young HY   Baek Hee Jo HJ   Kook Hoon H   Kim Seongkoo S   Lee Jae Wook JW   Chung Nack Gyun NG   Cho Bin B   Cho Seok Goo SG   Park Kyung Mi KM   Yang Eu Jeen EJ   Lim Young Tak YT   Suh Jin Kyung JK   Kang Sung Han SH   Kim Hyery H   Koh Kyung Nam KN   Im Ho Joon HJ   Seo Jong Jin JJ   Cho Hee Won HW   Ju Hee Young HY   Lee Ji Won JW   Yoo Keon Hee KH   Sung Ki Woong KW   Koo Hong Hoe HH   Park Kyung Duk KD   Hah Jeong Ok JO   Kim Min Kyoung MK   Han Jung Woo JW   Hahn Seung Min SM   Lyu Chuhl Joo CJ   Shim Ye Jee YJ   Kim Heung Sik HS   Do Young Rok YR   Yoo Jae Won JW   Lim Yeon Jung YJ   Jeon In Sang IS   Chueh Hee Won HW   Oh Sung Yong SY   Choi Hyoung Soo HS   Park Jun Eun JE   Lee Jun Ah JA   Park Hyeon Jin HJ   Park Byung Kiu BK   Kim Soon Ki SK   Lim Jae Young JY   Park Eun Sil ES   Park Sang Kyu SK   Choi Eun Jin EJ   Choi Young Bae YB   Yoon Jong Hyung JH  

Journal of Korean medical science 20201130 46


<h4>Background</h4>Hodgkin's lymphoma (HL) constitutes 10%-20% of all malignant lymphomas and has a high cure rate (5-year survival, around 90%). Recently, interest has increased concerning preventing secondary complications (secondary cancer, endocrine disorders) in long-term survivors. We aimed to study the epidemiologic features and therapeutic outcomes of HL in children, adolescents, and young adults in Korea.<h4>Methods</h4>We performed a multicenter, retrospective study of 224 patients age  ...[more]

Similar Datasets

| S-EPMC10998009 | biostudies-literature
| S-EPMC6722006 | biostudies-literature
| S-EPMC10565347 | biostudies-literature
| S-EPMC8482997 | biostudies-literature
2014-09-24 | GSE51813 | GEO
| S-EPMC7237935 | biostudies-literature
| S-EPMC6971196 | biostudies-literature
| S-EPMC8809576 | biostudies-literature
| S-EPMC6097078 | biostudies-other
| S-EPMC8410594 | biostudies-literature